MT1G inhibits the growth and epithelial-mesenchymal transition of gastric cancer cells by regulating the PI3K/AKT signaling pathway
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 45 (1) , e20210067
Abstract
Gastric carcinoma (GC) is a malignant tumor that has high mortality and morbidity worldwide. Although many efforts have been focused on the development and progression of GC, the underlying functional regulatory mechanism of GC needs more clarification. Metallothionein 1G (MT1G) is a member of the metallothionein family (MTs), and hypermethylation of MT1G occurred in a variety of cancers, including gastric cancer. However, the functional mechanism of MT1G in GC remains unclear. Here, we demonstrated that MT1G was down-regulated in GC tissues and cells. Overexpression of MT1G inhibited cell proliferation, foci formation and cell invasion, while knockdown of MT1G increased cell proliferation, foci formation and cell invasion. In addition, MT1G overexpression inhibited cell cycle progression and MT1G deficiency exerted opposite phenotype. p-AKT was negatively regulated by MT1G. In summary, our study reveals that MT1G exerts crucial role in regulating of cell proliferation and migration of gastric cancer, providing new insights for MT1G-related pathogenesis and a basis for developing new strategies for treatment of GC.Keywords
This publication has 36 references indexed in Scilit:
- MT1MandMT1Gpromoter methylation as biomarkers for hepatocellular carcinomaWorld Journal of Gastroenterology, 2014
- Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathwayNeoplasma, 2014
- Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathwayBMC Cancer, 2013
- Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survivalHuman Pathology, 2012
- Wnt/β-Catenin Signaling Enhances Cyclooxygenase-2 (COX2) Transcriptional Activity in Gastric Cancer CellsPLOS ONE, 2011
- MT1G Hypermethylation: A Potential Prognostic Marker for HepatoblastomaPediatric Research, 2010
- Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinomaLaboratory Investigation, 2008
- The Balance between Life and Death of Cells: Roles of MetallothioneinsBiomarker Insights, 2006
- Advances in metallothionein structure and functionsJournal of Trace Elements in Medicine and Biology, 2005
- Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinomaInternational Journal of Cancer, 2003